Beyond E-cadherin and PI3K pathways, the less frequent morphological and molecular features of ILC confer great interest, and these may account for the inter-tumour heterogeneity in the biological and clinical nature of this disease. The gene discussed is PIK3CA; the disease is neoplasm.